TCM
Teza Capital Management Portfolio holdings
AUM
$134M
1-Year Return
14.26%
This Quarter Return
+6.22%
1 Year Return
+14.26%
3 Year Return
+54.61%
5 Year Return
+108.25%
10 Year Return
–
AUM
$616M
AUM Growth
+$153M
(+33%)
Cap. Flow
+$134M
Cap. Flow
% of AUM
21.72%
Top 10 Holdings %
Top 10 Hldgs %
12.31%
Holding
766
New
280
Increased
142
Reduced
125
Closed
219
Top Buys
| 1 |
Bank of America
BAC
|
$9.46M |
| 2 |
Goldman Sachs
GS
|
$7.8M |
| 3 |
AbbVie
ABBV
|
$7.18M |
| 4 |
Microsoft
MSFT
|
$6.52M |
| 5 |
Johnson & Johnson
JNJ
|
$6.18M |
Top Sells
| 1 |
DuPont de Nemours
DD
|
$5.95M |
| 2 |
Walmart
WMT
|
$5.81M |
| 3 |
Amazon
AMZN
|
$5.72M |
| 4 |
Darden Restaurants
DRI
|
$4.93M |
| 5 |
Boston Scientific
BSX
|
$4.66M |
Sector Composition
| 1 | Technology | 18.09% |
| 2 | Financials | 14.21% |
| 3 | Consumer Discretionary | 13.12% |
| 4 | Industrials | 13.1% |
| 5 | Healthcare | 10.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
426
Edwards Lifesciences
EW
$47.5B
| $278K | 0.05% |
2,952
-10,686
| -78% | -$1.01M |
|
427
Synovus
SNV
$7.23B
| $278K | 0.05% |
+9,187
| New | +$278K |
|
428
Owens & Minor
OMI
$417M
| $277K | 0.05% |
+14,558
| New | +$277K |
|
429
Northern Trust
NTRS
$24.7B
| $277K | 0.04% |
+3,735
| New | +$277K |
|
430
Las Vegas Sands
LVS
$37.8B
| $274K | 0.04% |
+4,723
| New | +$274K |
|
431
Fidelity National Financial
FNF
$16.4B
| $273K | 0.04% |
+7,591
| New | +$273K |
|
432
Southern Copper
SCCO
$81.9B
| $273K | 0.04% |
+3,995
| New | +$273K |
|
433
Sprouts Farmers Market
SFM
$13.7B
| $272K | 0.04% |
+7,401
| New | +$272K |
|
434
Trimble
TRMB
$19B
| $271K | 0.04% |
5,115
-8,296
| -62% | -$439K |
|
435
H.B. Fuller
FUL
$3.31B
| $269K | 0.04% |
3,758
-535
| -12% | -$38.3K |
|
436
Okta
OKTA
$15.8B
| $269K | 0.04% |
+3,873
| New | +$269K |
|
437
First Financial Bankshares
FFIN
$5.29B
| $266K | 0.04% |
9,343
-601
| -6% | -$17.1K |
|
438
SEI Investments
SEIC
$11B
| $260K | 0.04% |
+4,363
| New | +$260K |
|
439
Regeneron Pharmaceuticals
REGN
$60.1B
| $258K | 0.04% |
+359
| New | +$258K |
|
440
Universal Health Services
UHS
$11.8B
| $258K | 0.04% |
1,633
-200
| -11% | -$31.6K |
|
441
EnerSys
ENS
$3.86B
| $257K | 0.04% |
+2,372
| New | +$257K |
|
442
Kinsale Capital Group
KNSL
$10.7B
| $257K | 0.04% |
+687
| New | +$257K |
|
443
Globant
GLOB
$2.75B
| $257K | 0.04% |
1,429
-552
| -28% | -$99.2K |
|
444
John Wiley & Sons Class A
WLY
$2.04B
| $255K | 0.04% |
+7,484
| New | +$255K |
|
445
O'Reilly Automotive
ORLY
$89.1B
| $254K | 0.04% |
3,990
+195
| +5% | +$12.4K |
|
446
Lithia Motors
LAD
$8.72B
| $254K | 0.04% |
835
-480
| -37% | -$146K |
|
447
United Therapeutics
UTHR
$17.2B
| $254K | 0.04% |
+1,150
| New | +$254K |
|
448
Perrigo
PRGO
$3.2B
| $251K | 0.04% |
+7,389
| New | +$251K |
|
449
Royalty Pharma
RPRX
$16B
| $250K | 0.04% |
+8,147
| New | +$250K |
|
450
Gentex
GNTX
$6.17B
| $250K | 0.04% |
+8,538
| New | +$250K |
|